Value Star Asset Management (Hong Kong) Ltd - CRISPR Therapeutics AG ownership

CRISPR Therapeutics AG's ticker is and the CUSIP is 033408113. A total of 1 filers reported holding CRISPR Therapeutics AG in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Value Star Asset Management (Hong Kong) Ltd ownership history of CRISPR Therapeutics AG
ValueSharesWeighting
Q3 2023$801,133
-19.1%
17,6500.0%0.28%
-3.4%
Q2 2023$990,871
+70.5%
17,650
+37.4%
0.29%
+29.1%
Q1 2023$581,20512,8500.23%
Other shareholders
CRISPR Therapeutics AG shareholders Q1 2023
NameSharesValueWeighting ↓
Value Star Asset Management (Hong Kong) Ltd 12,850$581,2050.23%
View complete list of CRISPR Therapeutics AG shareholders